A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Eletriptan Hydrobromide (Relpax)

Serotonin-1b and Serotonin-1d Receptor Agonist class · 7 generic manufacturers · 14 ANDAs filed at FDA.

First FDA approval2002-12-26
Generic availableYes · 7 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$13.0M in CY2024 Part D spend104K claims · 31K beneficiaries · 329 plans surveyed

Lowest NADAC
$1.87/unit
16 NDCs benchmarked, lowest of all strengths.
Average NADAC
$25.53
Across all dosage forms in distribution.
Highest NADAC
$77.59
Wide spread — brand-strength NDCs still in market.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema12 entries indexed · 4 visible
What is Eletriptan Hydrobromide used for?

Eletriptan Hydrobromide is a Serotonin-1b and Serotonin-1d Receptor Agonist medication tracked in Medicare Part D.

Is there a generic for Eletriptan Hydrobromide?

Yes. 14 ANDAs filed at FDA, 7 generic manufacturers currently shipping.

How much does my plan pay for Eletriptan Hydrobromide?

Across 329 Part D plans, Eletriptan Hydrobromide averages $25.53/unit (NADAC). Lowest available: $1.87/unit. Highest in distribution: $77.59/unit.

Is Eletriptan Hydrobromide on the FDA shortage list?

No. Eletriptan Hydrobromide is not currently on the FDA Drug Shortage Database.

8 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Serotonin-1b and Serotonin-1d Receptor Agonist3 alternatives in D1
01
Rizatriptan
Brand: MAXALT
$0.484Lowest NADAC
7Generic mfrs
$26.3MCY24 Part D spend
Compare →
02
Sumatriptan
Brand: IMITREX
$0.258Lowest NADAC
21Generic mfrs
$83.8MCY24 Part D spend
Compare →
03
Zolmitriptan
Brand: ZOMIG
$1.05Lowest NADAC
10Generic mfrs
$11.4MCY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (16 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.